Multiplexed bead-based immunoassays
Mayflower Bioscience has entered into a distribution agreement with Aimplex Biosciences Company, the developer of the AimPlexTM multiplex technology. AimPlex is a bead-based multiplex technology allowing analysis of up to 24 analytes in a single reaction which is read on a standard flow cytometer. Similar in principle to a sandwich ELISA, a bead-bound capture antibody reacts with analyte in the sample followed by a biotinylated secondary antibody to a different epitope on the analyte and a subsequent incubation with streptavidin-R-phycoerythrin. Analyte quantitation is performed using existing flow cytometry analytical platforms. There are currently more than 365 immunoassays available for both single or multiplex analyte detection. In addition to Premixed Multiplex Panels, customers can customize panels to fit their specific requirements at no additional charge. With a large assay inventory and ease of customization, AimPlex improves the efficiency and performance of multiplex assays.
